David Henderson

University of Glasgow — United Kingdom

Neuroscience · Life Sciences

20h-index4.5kcitations48works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(8), Job Satisfaction and Organizational Behavior(7), Receptor Mechanisms and Signaling(7), Radiopharmaceutical Chemistry and Applications(7), Phosphodiesterase function and regulation(7)

Publications48 total

Targeting Troponin I Phosphorylation for Precision Treatment of Diastolic Dysfunction
2025Open Access
Penal servitude: convicts and long-term imprisonment, 1853-1948
Policing & Society·2025
Navigating the Translation of LoAc Compound Efficacy in ADPKD
Journal of the American Society of Nephrology·2024
Book review: Halfway Home: Race, Punishment and the Afterlife of Mass Incarceration
Probation Journal·2022
A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation
EMBO Reports·2022· 54 citedOpen Access
Pharmacological Activation of Long-Form PDE4 Enzymes Suppresses Disease Progression in Pkd1RC/RC and Pkd1 Knockout (iKspCrePkd-1lox,lox) Mouse Models of ADPKD
Journal of the American Society of Nephrology·2021
Synthesis and pharmacological evaluation of [<sup>18</sup>F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971
RSC Medicinal Chemistry·2021· 12 citedOpen Access
Small-Molecule Allosteric Activators of Long-Form PDE4 Enzymes Suppress Cystogenesis in Models of ADPKD
Journal of the American Society of Nephrology·2020· 1 cited
Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
Proceedings of the National Academy of Sciences·2019· 77 citedOpen Access
The β-NAD+ salvage pathway and PKC-mediated signaling influence localized PARP-1 activity and CTCF Poly(ADP)ribosylation
Oncotarget·2017· 9 citedOpen Access
Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111
European Journal of Nuclear Medicine and Molecular Imaging·2016· 24 cited
Evaluation of 18F-TSPO radiotracers in a prostate tumour model using PET.
2015
Toward an Understanding of When and Why Servant Leadership Accounts for Employee Extra-Role Behaviors
Journal of Business and Psychology·2014· 171 cited
Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression
Cellular Signalling·2014· 27 cited
Synthesis of [11C]PBR170, a novel imidazopyridine, for imaging the translocator protein with PET
Applied Radiation and Isotopes·2014· 3 cited
Understanding Differentiated Leadership in Teams
Academy of Management Proceedings·2012
Radiation dosimetry of the translocator protein ligands [18F]PBR111 and [18F]PBR102
Nuclear Medicine and Biology·2012· 15 cited
Preparation and quality control of 4-[F-18] Fluorobenzaldehyde : a versatile intermediate for PET tracer syntheses
Queensland's institutional digital repository (The University of Queensland)·2012
Phosphodiesterase expression during the progression of prostate cancer: the significance of PDE4D7
2012
Automated radiosynthesis of [18F]PBR111 and [18F]PBR102 using the Tracerlab FXFN and Tracerlab MXFDG module for imaging the peripheral benzodiazepine receptor with PET
Applied Radiation and Isotopes·2011· 21 cited
page 1 of 3Next →

Frequent Co-authors

Michael Fulham(12), Stefan Eberl(8), Andrew Katsifis(7), Filomena Mattner(7), Sandy J. Wayne(6), Michael Kassiou(6), Christian Loc’h(6), Peter Lam(6), Thomas Bourdier(6), Roger Fulton(5), Miles D. Houslay(5), Tien Pham(5), George S. Baillie(4), Julia M. Adam(4), Ivan Greguric(4), Jordan Verschuer(4), Robert C. Liden(3), Tanguy Dulac(3), Jacqueline A‐M. Coyle‐Shapiro(3), Denis Guilloteau(3)